FDA — authorised 10 February 2010
- Application: NDA022417
- Marketing authorisation holder: ABBVIE
- Status: supplemented
FDA authorised Norvir on 10 February 2010
Yes. FDA authorised it on 10 February 2010; FDA authorised it on 7 June 2017; FDA has authorised it.
ABBVIE holds the US marketing authorisation.